Madrigal Pharmaceuticals Inc (MDGL)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
11,934,668,000
EV to revenue ratio (TTM)
8.85
EV to ebitda
-8.32
Financial Performance
Revenue (TTM)
1,283,940,000
Gross profit (TTM)
1,174,516,000
EBITDA
-321,097,984
Profitability
Operating margin (TTM)
-15.50%
Profit margin
-25.30%
Return on assets (TTM)
-17.80%
Return on equity (TTM)
-53.30%
Per Share Metrics
Revenue per share (TTM)
56.15
EPS
-14
Diluted EPS (TTM)
-14
Book value
22.68
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
78.12
PEG ratio
0
Price to sales ratio (TTM)
9.3
Price to book ratio (TTM)
22.63
Growth
Quarterly earnings growth (YoY)
71.20%
Quarterly revenue growth (YoY)
0.00%
Analyst Sentiment
Strong buy
3
Buy
13
Hold
1
Sell
0
Strong sell
0
Risk & Volatility
Beta
-0.99